Florida

Florida

348,658
Registered Patient Population
1.62%
of Total Population Represented by Patients
250
Total Medical Retail Locations Currently in Operation
1,395 : 1
Patients : Retail

Medical cannabis is legal in Florida; however, patients report limited access due to high prices. They also have concerns regarding the quality of the medicine in Florida and its lack of product variety. Patients and caregivers in Florida may possess up to 4 ounces. There is no reciprocity for out of state patients in Florida

Patient Rights and Civil Protection 69/100   
Arrest Protection 40/40
Affirmative Defense 13/15
Parental Rights Protections 0/10
DUI Protections 0/5
Employment Protections 5/5
Explicit Privacy Standards 7/7
Housing Protections 0/5
Does Not Create New Criminal Penalties for Patients 4/5
Organ Transplants 0/5
Reciprocity 0/3
Access to Medicine 67/100   
Allows Distribution Programs 35/40
– Allows Access to Dried Flowers 15/15
– Allows Delivery 5/5
– No Sales Tax or Reasonable Sales Tax 5/5
– Allows for a Reasonable Number of Dispensaries 5/5
– Does Not Require Vertical Integration 0/2
– Ownership/Employment Restrictions 1/2
– Provisions for Labor Standards 2/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 2/2
Noncommercial Cultivation 2/20
– Personal Cultivation 2/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 9/10
Does not Impose Bans or Limits on THC 9/10
Does not Impose Bans on CBD 4/10
Local Bans/Zoning 8/10
Comprehensive Qualifying Conditions 45/50
Adding New Conditions 7/10
– Law/Regulations Allow for New Conditions 5/5
– System Works for Adding New Conditions 2/5
Reasonable Access for Minors 8/10
Reasonable Caregiver Background Checks 0/4
Number of Caregivers 0/2
Patient/Practitioner-Focused Task Force or Advisory Board 0/2
Reasonable Fees (Patients and Caregivers) 5/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 5/5
Does Not Classify Cannabis as a Medicine of Last Resort 5/5
Functionality 71/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 40/50
No Significant Administrative or Supply Problems 10/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 8/10
Reasonable Possession Limits 5/5
Reasonable Purchase Limits 5/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 0/7
Consumer Safety and Provider Requirements 70.83/100   
Dispensing 21.34/25
Staff Training 5/5
Standard Operating Procedures 5/5
– Facility Sanitary Conditions 1.25/1.25
– Storage Protocols 1.25/1.25
– Reasonable Security Protocols 1.25/1.25
– Inventory Control 1.25/1.25
Recall Protocol and Adverse Event Reporting 5/5
Product Labeling 3.34/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency/Compound Identification 1.67/1.67
Required Testing 3/5
– Active Compound Identification 1/1.67
– Contaminants 1/1.67
– Potency 1/1.67
Grow/Cultivation 21.00/25
Staff Training 5/5
Standard Operating Procedures 5/5
– Facility and Equipment Sanitary Conditions 0.71/0.71
– Workforce Safety Protocols 0.71/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0.71/0.71
– Reasonable Security Protocols 0.71/0.71
– Batch and Lot Tracking 0.71/0.71
– Disposal/Waste 0.71/0.71
– Water Management 0.71/0.71
Pesticide Guidance 4/5
– Pesticide Guidance 2/2.5
– Pesticide Labeling 2/2.5
Required Testing 2/5
– Active Ingredient Identification 1/1.25
– Contaminants 0/1.25
– Potency 1/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 5/5
Manufacturing 21/25
Staff Training 5/5
Standard Operating Procedures 5/5
– Facility and Equipment Sanitary Conditions 1/1
– Workforce Safety Protocols 1/1
– Storage Protocols 1/1
– Reasonable Security Protocols 1/1
– Batch and Lot Tracking 1/1
Product Labeling 2/5
– Product Contents, Including Source Material Identification 1/1.67
– Allergens /1.67
– Potency and Compound Information 1/1.67
Required Testing 4/5
– Active Ingredient Identification 1/1
– Contaminants 1/1
– Potency 1/1
– Shelf Life Testing 0/1
– Sample Retention 1/1
Recall Protocol and Adverse Event Reporting 5/5
Laboratory Operations 7.49/25
Staff Training 0/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 5/5
Independent or Third Party 0/5
Standard Operating Procedures and Protocols 2.49/5
– Equipment and Instrument Calibration 0.83/0.83
– Sample Tracking 0.83/0.83
– Facility and Equipment Sanitary Conditions 0/0.83
– Disposal/Waste 0/0.83
– Storage Protocols 0.83/0.83
– Workforce Safety Protocols 0/0.83
Covid Response 18/20   
Delivery Available? 6/6
Curbside Pickup Available? 2/2
Medical Cannabis Essential? 7/7
Telemedicine Available? 3/5
Excerpted from ASA's 2020 State of the States Report.
page icon

Florida Medical Marijuana Laws and Regulations

page icon

Becoming a Patient in Florida

page icon

Recommending Cannabis in Florida

page icon

Becoming a Caregiver, Producer or Provider in Florida

page icon

The State of Medical Marijuana in Florida